Clinical Trial Update: Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from Nanfang Hospital/Southern Medical University evaluating mesenchymal stem cells combined with umbilical cord blood to treat gr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Failure
• Hematologic Diseases

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cells | Phase 2 | Status: UNKNOWN